New! Sign up for our free email newsletter.
Science News
from research organizations

Researchers shed light on genetic mechanisms of Wilms tumor

Date:
May 24, 2022
Source:
Ann & Robert H. Lurie Children's Hospital of Chicago
Summary:
New research provides insights into some of the genetic characteristics resulting in the development of relapse in patients with Wilms tumor (nephroblastoma), the most common type of pediatric cancer of the kidney. The study identified mutations in key genes, including two that had not been previously recognized in Wilms tumor, which offers promise for improving ways to better identify patients who are at risk of relapse and tailoring therapies for these patients.
Share:
FULL STORY

New research from Ann & Robert H. Lurie Children's Hospital of Chicago and collaborators from other institutions provides insights into some of the genetic characteristics resulting in the development of relapse in patients with Wilms tumor (nephroblastoma), the most common type of pediatric cancer of the kidney. The study published in Cell Reports Medicine identified mutations in key genes, including two that had not been previously recognized in Wilms tumor, which offers promise for improving ways to better identify patients who are at risk of relapse and tailoring therapies for these patients.

There are two major types of Wilms tumor based on their histology, or how they look under a microscope. Approximately 95 percent of Wilms tumors have a favorable histology, and the overall survival rate of children with tumors of this type is 90 percent. Unfavorable histology, or anaplasia, describes tumors with increase in cell size, increased irregularity in the shape of the cells, and abnormalities of DNA. These tumors are more difficult to treat. Even though children with favorable histology Wilms tumor have a very high rate of overall survival, they still require treatment with chemotherapy, and often with radiation as well.

To gain a better understanding of the genetic mechanisms of relapse in Wilms tumors, the researchers conducted genetic sequencing of samples from primary and relapse tumors as well as normal kidney or peripheral blood samples of patients with favorable histology Wilms tumor who relapsed following therapy. The patients were part of the Children's Oncology Group AREN03B2 umbrella biology and classification study from 2006 to 2017.

"One of the remarkable characteristics of this study is that it is a comprehensive analysis of the largest number of relapse samples of Wilms tumor to date," said lead author Elizabeth J. Perlman, Head of the Department of Pathology and Laboratory Medicine, Arthur C. King Board Designated Professor at Lurie Children's Hospital, and Professor of Pathology at Northwestern University Feinberg School of Medicine. "We were also able to build upon current evidence suggesting that genetic variants may play key roles in tumor evolution."


Story Source:

Materials provided by Ann & Robert H. Lurie Children's Hospital of Chicago. Note: Content may be edited for style and length.


Journal Reference:

  1. Samantha Gadd et al. Genetic changes associated with relapse in favorable histology Wilms tumor: A Children’s Oncology Group AREN03B2 study. Cell Reports Medicine, 2022 DOI: 10.1016/j.xcrm.2022.100644

Cite This Page:

Ann & Robert H. Lurie Children's Hospital of Chicago. "Researchers shed light on genetic mechanisms of Wilms tumor." ScienceDaily. ScienceDaily, 24 May 2022. <www.sciencedaily.com/releases/2022/05/220524124845.htm>.
Ann & Robert H. Lurie Children's Hospital of Chicago. (2022, May 24). Researchers shed light on genetic mechanisms of Wilms tumor. ScienceDaily. Retrieved November 20, 2024 from www.sciencedaily.com/releases/2022/05/220524124845.htm
Ann & Robert H. Lurie Children's Hospital of Chicago. "Researchers shed light on genetic mechanisms of Wilms tumor." ScienceDaily. www.sciencedaily.com/releases/2022/05/220524124845.htm (accessed November 20, 2024).

Explore More

from ScienceDaily

RELATED STORIES